Personalized Medicine
PM is an innovative medical tool that offers customization of medical decisions, treatments and practices for a specific individual in contrast to the conventional one‐drug‐fits‐all model.
PM enables diagnostic tests for selecting appropriate and optimal therapies based on the context of an individual patient’s genetic content or other molecular or cellular analysis.
Proteomic biomarkers integrated with pharmacogenomics enable patient-specific diagnostics and therapeutics as well as stratification of clinical trials.
PM services include:
- Biomarker discovery from patient samples for early detection of various diseases
- Patient-specific proteome profiling enabling;
- Patient-specific therapeutic/diagnostic target development
- Patient-specific solution for therapy selection
- Decipher proteome signature
Target disease
- Cancers
- Neurodegenerative diseases
